{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:05:37Z","timestamp":1794715537535,"version":"4.9.1"},"reference-count":76,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>\n                      Brain arteriovenous malformations (bAVMs) are rare but potentially devastating cerebrovascular lesions. Activating\n                      <jats:italic>KRAS<\/jats:italic>\n                      mutations are common in sporadic bAVMs, but their clinical implications remain unclear. The aim of this study was to investigate a novel therapeutic strategy for hemorrhagic bAVMs based on dual inhibition of the mitogen-activated protein kinase (MAPK) and vascular endothelial growth factor (VEGF) pathways using an engineered mouse model with a titratable\n                      <jats:italic>KRAS<\/jats:italic>\n                      <jats:sup>G12V<\/jats:sup>\n                      -\n                      <jats:italic>GFP<\/jats:italic>\n                      transgene.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>\n                      The AAV-BR1-CAG vector was used to deliver a\n                      <jats:italic>KRAS<\/jats:italic>\n                      <jats:sup>G12V<\/jats:sup>\n                      -\n                      <jats:italic>GFP<\/jats:italic>\n                      transgene specifically to cerebral endothelial cells. Mice received 5 \u00d7 10\n                      <jats:sup>7<\/jats:sup>\n                      to 5 \u00d7 10\n                      <jats:sup>10<\/jats:sup>\n                      genome copies of the vector, and bAVM formation, intracerebral hemorrhage (ICH), and overall survival were assessed. Mice with established hemorrhagic bAVMs were subsequently treated with trametinib (MEK inhibitor) or RMC-7977 (RAS inhibitor), with or without an anti\u2013mouse VEGF antibody, starting 4 weeks after viral delivery. Overall survival was assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Selective overexpression of\n                      <jats:italic>KRAS<\/jats:italic>\n                      <jats:sup>G12V<\/jats:sup>\n                      -\n                      <jats:italic>GFP<\/jats:italic>\n                      in cerebral endothelial cells led to the formation of bAVMs in a dose-dependent manner. Mice that received the highest transgene dose developed significantly more bAVMs, exhibited a higher ICH burden, and had worse overall survival compared with those that received lower transgene doses. In mice receiving the highest transgene dose, trametinib alone modestly improved the median overall survival (8.4 weeks vs 6.4 weeks, p = 0.049), while single-agent RMC-7977 showed no significant benefit. Anti-VEGF therapy alone reduced survival (6.9 weeks vs 9.6 weeks, p = 0.044). However, combination therapy with trametinib or RMC-7977 and anti-VEGF antibody significantly prolonged survival, with the most pronounced benefit seen in the RMC-7977 plus anti-VEGF group (13.1 weeks vs 6.7 weeks in controls, p = 0.024).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>\n                      Our findings suggest that, in addition to promoting bAVM formation,\n                      <jats:italic>KRAS<\/jats:italic>\n                      mutations in cerebral endothelial cells might be causally implicated in bAVM rupture. Additionally, concomitant inhibition of the MAPK and VEGF pathways could be a promising novel therapeutic strategy for\n                      <jats:italic>KRAS<\/jats:italic>\n                      -mutated bAVMs.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2025.7.jns25708","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:40:51Z","timestamp":1761961251000},"page":"452-461","source":"Crossref","is-referenced-by-count":4,"title":["Dual MAPK\/VEGF inhibition for KRAS-mutated brain arteriovenous malformations"],"prefix":"10.3171","volume":"144","author":[{"given":"Ryan M.","family":"Naylor","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Ueki","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota;"},{"name":"Department of Neurosurgery, Graduate School of Medicine, University of Juntendo, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatmah R.","family":"Alsereidi","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota;"},{"name":"Cardiovascular Research Group, Research Institute for Medical and Health Sciences, University of Sharjah, United Arab Emirates;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delal","family":"Bektas","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota;"},{"name":"Department of Neurosurgery, University Hospital Zurich, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Haugen","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Kadirvel","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota;"},{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"3","key":"b1","series-title":"J Neurosurg","first-page":"352","article-title":"The natural-history of unruptured intracranial arteriovenous-malformations","volume":"68","author":"Brown RD","year":"1988","unstructured":"Brown RD, Wiebers DO, Forbes G,  The natural-history of unruptured intracranial arteriovenous-malformations. J Neurosurg. 1988;68(3):352\u2013357."},{"issue":"4","key":"b2","series-title":"J Neurosurg","first-page":"476","article-title":"A proposed grading system for arteriovenous malformations","volume":"65","author":"Spetzler RF","year":"1986","unstructured":"Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65(4):476\u2013483."},{"issue":"1","key":"b3","series-title":"J Neurosurg","first-page":"125","article-title":"Intermediate-grade brain arteriovenous malformations and the boundary of operability using the supplemented Spetzler-Martin grading system","volume":"136","author":"Catapano JS","year":"2022","unstructured":"Catapano JS, Frisoli FA, Nguyen CL,  Intermediate-grade brain arteriovenous malformations and the boundary of operability using the supplemented Spetzler-Martin grading system. J Neurosurg. 2022;136(1):125\u2013133."},{"issue":"6","key":"b4","series-title":"Neurosurgery","first-page":"1103","article-title":"Spetzler-Martin grade III arteriovenous malformations: a comparison of modified and supplemented Spetzler-Martin grading systems","volume":"88","author":"Frisoli FA","year":"2021","unstructured":"Frisoli FA, Catapano JS, Farhadi DS,  Spetzler-Martin grade III arteriovenous malformations: a comparison of modified and supplemented Spetzler-Martin grading systems. Neurosurgery. 2021;88(6):1103\u20131110."},{"issue":"2","key":"b5","series-title":"Oper Neurosurg (Hagerstown)","first-page":"136","article-title":"More II it than meets the eye: outcomes after single-fraction stereotactic radiosurgery in a case series of low-grade arteriovenous malformations","volume":"18","author":"Graffeo CS","year":"2020","unstructured":"Graffeo CS, Link MJ, Stafford SL, Garces YI, Foote RL, Pollock BE. More II it than meets the eye: outcomes after single-fraction stereotactic radiosurgery in a case series of low-grade arteriovenous malformations. Oper Neurosurg (Hagerstown). 2020;18(2):136\u2013144."},{"issue":"3","key":"b6","series-title":"J Neurosurg","first-page":"804","article-title":"Stereotactic radiosurgery for intermediate- and high-grade arteriovenous malformations: outcomes stratified by the supplemented Spetzler-Martin grading system","volume":"138","author":"Naylor RM","year":"2023","unstructured":"Naylor RM, Graffeo CS, Nesvick CL,  Stereotactic radiosurgery for intermediate- and high-grade arteriovenous malformations: outcomes stratified by the supplemented Spetzler-Martin grading system. J Neurosurg. 2023;138(3):804\u2013809."},{"issue":"3","key":"b7","series-title":"J Neurosurg","first-page":"859","article-title":"Stereotactic radiosurgery for Spetzler-Martin Grade III arteriovenous malformations: an international multicenter study","volume":"126","author":"Ding D","year":"2017","unstructured":"Ding D, Starke RM, Kano H,  Stereotactic radiosurgery for Spetzler-Martin Grade III arteriovenous malformations: an international multicenter study. J Neurosurg. 2017;126(3):859\u2013871."},{"issue":"2","key":"b8","series-title":"J Neurosurg","first-page":"498","article-title":"Stereotactic radiosurgery for Spetzler-Martin Grade IV and V arteriovenous malformations: an international multicenter study","volume":"129","author":"Patibandla MR","year":"2018","unstructured":"Patibandla MR, Ding D, Kano H,  Stereotactic radiosurgery for Spetzler-Martin Grade IV and V arteriovenous malformations: an international multicenter study. J Neurosurg. 2018;129(2):498\u2013507."},{"issue":"1","key":"b9","series-title":"Brain","first-page":"23","article-title":"High prevalence of KRAS\/BRAF somatic mutations in brain and spinal cord arteriovenous malformations","volume":"142","author":"Hong T","year":"2019","unstructured":"Hong T, Yan Y, Li J,  High prevalence of KRAS\/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. Brain. 2019;142(1):23\u201334."},{"issue":"3","key":"b10","series-title":"N Engl J Med","first-page":"250","article-title":"Somatic activating KRAS mutations in arteriovenous malformations of the brain","volume":"378","author":"Nikolaev SI","year":"2018","unstructured":"Nikolaev SI, Vetiska S, Bonilla X,  Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med. 2018;378(3):250\u2013261."},{"issue":"4","key":"b11","series-title":"N Engl J Med","first-page":"334","article-title":"Sotorasib for vascular malformations associated with KRAS G12C Mutation","volume":"391","author":"Fraissenon A","year":"2024","unstructured":"Fraissenon A, Bayard C, Morin G,  Sotorasib for vascular malformations associated with KRAS G12C Mutation. N Engl J Med. 2024;391(4):334\u2013342."},{"issue":"5","key":"b12","series-title":"Ann Neurol","first-page":"926","article-title":"Selective endothelial hyperactivation of oncogenic KRAS induces brain arteriovenous malformations in mice","volume":"89","author":"Park ES","year":"2021","unstructured":"Park ES, Kim S, Huang S,  Selective endothelial hyperactivation of oncogenic KRAS induces brain arteriovenous malformations in mice. Ann Neurol. 2021;89(5):926\u2013941."},{"issue":"6","key":"b13","series-title":"EMBO Mol Med","first-page":"609","article-title":"A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases","volume":"8","author":"K\u00f6rbelin J","year":"2016","unstructured":"K\u00f6rbelin J, Dogbevia G, Michelfelder S,  A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases. EMBO Mol Med. 2016;8(6):609\u2013625."},{"issue":"8013","key":"b14","series-title":"Nature","first-page":"927","article-title":"Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer","volume":"629","author":"Wasko UN","year":"2024","unstructured":"Wasko UN, Jiang J, Dalton TC,  Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Nature. 2024;629(8013):927\u2013936."},{"issue":"3","key":"b15","series-title":"Cancer Discov","first-page":"270","article-title":"Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors","volume":"2","author":"Sennino B","year":"2012","unstructured":"Sennino B, Ishiguro-Oonuma T, Wei Y,  Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Cancer Discov. 2012;2(3):270\u2013287."},{"key":"b16","series-title":"Front Immunol","first-page":"726421","article-title":"Microglia and perivascular macrophages act as antigen presenting cells to promote CD8 T cell infiltration of the brain","volume":"12","author":"Goddery EN","year":"2021","unstructured":"Goddery EN, Fain CE, Lipovsky CG,  Microglia and perivascular macrophages act as antigen presenting cells to promote CD8 T cell infiltration of the brain. Front Immunol. 2021;12:726421."},{"issue":"1","key":"b17","series-title":"Neuroradiology","first-page":"65","article-title":"Lack of aneurysm formation after carotid artery ligation in rabbits: a polymer MICROFIL\u00ae study","volume":"55","author":"Dai D","year":"2013","unstructured":"Dai D, Ding YH, Kadirvel R, Rad AE, Lewis DA, Kallmes DF. Lack of aneurysm formation after carotid artery ligation in rabbits: a polymer MICROFIL\u00ae study. Neuroradiology. 2013;55(1):65\u201370."},{"issue":"6","key":"b18","series-title":"Nat Cell Biol","first-page":"538","article-title":"Cyclin B2 and p53 control proper timing of centrosome separation","volume":"16","author":"Nam HJ","year":"2014","unstructured":"Nam HJ, van Deursen JM. Cyclin B2 and p53 control proper timing of centrosome separation. Nat Cell Biol. 2014;16(6):538\u2013549."},{"issue":"1","key":"b19","series-title":"Cardiovasc Diabetol","first-page":"388","article-title":"Dapagliflozin mitigates cellular stress and inflammation through PI3K\/AKT pathway modulation in cardiomyocytes, aortic endothelial cells, and stem cell-derived \u03b2 cells","volume":"23","author":"Alsereidi FR","year":"2024","unstructured":"Alsereidi FR, Khashim Z, Marzook H,  Dapagliflozin mitigates cellular stress and inflammation through PI3K\/AKT pathway modulation in cardiomyocytes, aortic endothelial cells, and stem cell-derived \u03b2 cells. Cardiovasc Diabetol. 2024;23(1):388."},{"issue":"7","key":"b20","series-title":"Nat Methods","first-page":"676","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin J","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E,  Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u2013682."},{"issue":"7","key":"b21","series-title":"Stroke","first-page":"1925","article-title":"Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain","volume":"43","author":"Walker EJ","year":"2012","unstructured":"Walker EJ, Su H, Shen F,  Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain. Stroke. 2012;43(7):1925\u20131930."},{"issue":"5","key":"b22","series-title":"J Neurosurg","first-page":"1566","article-title":"Effect of elevation of vascular endothelial growth factor level on exacerbation of hemorrhage in mouse brain arteriovenous malformation","volume":"132","author":"Cheng P","year":"2020","unstructured":"Cheng P, Ma L, Shaligram S,  Effect of elevation of vascular endothelial growth factor level on exacerbation of hemorrhage in mouse brain arteriovenous malformation. J Neurosurg. 2020;132(5):1566\u20131573."},{"issue":"3","key":"b23","series-title":"JAMA Netw Open","first-page":"e231070","article-title":"Development and validation of a scoring system for hemorrhage risk in brain arteriovenous malformations","volume":"6","author":"Chen Y","year":"2023","unstructured":"Chen Y, Han H, Meng X,  Development and validation of a scoring system for hemorrhage risk in brain arteriovenous malformations. JAMA Netw Open. 2023;6(3):e231070."},{"key":"b24","series-title":"JVS Vasc Sci","first-page":"176","article-title":"Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation","volume":"1","author":"Palmieri M","year":"2020","unstructured":"Palmieri M, Curr\u00f2 A, Tommasi A,  Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation. JVS Vasc Sci. 2020;1:176\u2013180."},{"issue":"16","key":"b25","series-title":"Neurology","first-page":"e1637","article-title":"Endoluminal biopsy for molecular profiling of human brain vascular malformations","volume":"98","author":"Winkler E","year":"2022","unstructured":"Winkler E, Wu D, Gil E,  Endoluminal biopsy for molecular profiling of human brain vascular malformations. Neurology. 2022;98(16):e1637\u2013e1647."},{"issue":"4","key":"b26","series-title":"Cancer Cell","first-page":"299","article-title":"Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors","volume":"8","author":"Casanovas O","year":"2005","unstructured":"Casanovas O, Hicklin DJ, Bergers G, Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell. 2005;8(4):299\u2013309."},{"issue":"52","key":"b27","series-title":"J Biol Chem","first-page":"49289","article-title":"Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation","volume":"276","author":"Meadows KN","year":"2001","unstructured":"Meadows KN, Bryant P, Pumiglia K. Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J Biol Chem. 2001;276(52):49289\u201349298."},{"issue":"6","key":"b28","series-title":"Biomedicines","first-page":"1289","article-title":"Defining the role of oral pathway inhibitors as targeted therapeutics in arteriovenous malformation care","volume":"12","author":"Mansur A","year":"2024","unstructured":"Mansur A, Radovanovic I. Defining the role of oral pathway inhibitors as targeted therapeutics in arteriovenous malformation care. Biomedicines. 2024;12(6):1289."},{"issue":"2","key":"b29","series-title":"Ther Adv Drug Saf","first-page":"59","article-title":"Risks and benefits with bevacizumab: evidence and clinical implications","volume":"3","author":"Kurkjian C","year":"2012","unstructured":"Kurkjian C, Kim ES. Risks and benefits with bevacizumab: evidence and clinical implications. Ther Adv Drug Saf. 2012;3(2):59\u201369."},{"issue":"2","key":"b30","series-title":"J Thorac Oncol","first-page":"268","article-title":"Rupture of a cerebral arteriovenous malformation in a patient treated with bevacizumab","volume":"4","author":"Tanvetyanon T","year":"2009","unstructured":"Tanvetyanon T, Murtagh R, Bepler G. Rupture of a cerebral arteriovenous malformation in a patient treated with bevacizumab. J Thorac Oncol. 2009;4(2):268\u2013269."},{"issue":"1","key":"b31","series-title":"BMJ Neurol Open","first-page":"e000114","article-title":"Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation","volume":"3","author":"Muster R","year":"2021","unstructured":"Muster R, Ko N, Smith W,  Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation. BMJ Neurol Open. 2021;3(1):e000114."},{"issue":"3","key":"b32","series-title":"Pediatrics","first-page":"e20193206","article-title":"Monitoring arteriovenous malformation response to genotype-targeted therapy","volume":"146","author":"Edwards EA","year":"2020","unstructured":"Edwards EA, Phelps AS, Cooke D,  Monitoring arteriovenous malformation response to genotype-targeted therapy. Pediatrics. 2020;146(3):e20193206."},{"issue":"2","key":"b33","series-title":"JAMA Dermatol","first-page":"256","article-title":"Genotype-guided medical treatment of an arteriovenous malformation in a child","volume":"155","author":"Lekwuttikarn R","year":"2019","unstructured":"Lekwuttikarn R, Lim YH, Admani S, Choate KA, Teng JMC. Genotype-guided medical treatment of an arteriovenous malformation in a child. JAMA Dermatol. 2019;155(2):256\u2013257."},{"issue":"2","key":"b34","series-title":"Pediatr Dermatol","first-page":"316","article-title":"Successful management of an arteriovenous malformation with trametinib in a patient with capillary-malformation arteriovenous malformation syndrome and cardiac compromise","volume":"39","author":"Nicholson CL","year":"2022","unstructured":"Nicholson CL, Flanagan S, Murati M,  Successful management of an arteriovenous malformation with trametinib in a patient with capillary-malformation arteriovenous malformation syndrome and cardiac compromise. Pediatr Dermatol. 2022;39(2):316\u2013319."},{"issue":"Suppl 1","key":"b35","series-title":"Blood","first-page":"5418","article-title":"Response to dabrafenib and tramatenib in an extra-cranial AVM with BRAF V600E Mutation","volume":"142","author":"Fraustro M","year":"2023","unstructured":"Fraustro M, Olsen B, Khatib Z. Response to dabrafenib and tramatenib in an extra-cranial AVM with BRAF V600E Mutation. Blood. 2023;142(Suppl 1):5418."},{"issue":"3","key":"b36","series-title":"J Vasc Anom (Phila)","first-page":"e018","article-title":"Angiographic evidence of response to trametinib therapy for a spinal cord arteriovenous malformation","volume":"2","author":"Cooke DL","year":"2021","unstructured":"Cooke DL, Frieden IJ, Shimano KA. Angiographic evidence of response to trametinib therapy for a spinal cord arteriovenous malformation. J Vasc Anom (Phila). 2021;2(3):e018."},{"issue":"Suppl 1","key":"b37","series-title":"J Neurointerv Surg","first-page":"A243","article-title":"LB-002 Liquid biopsy identifies somatic KRAS mutations in paediatric cranio-spinal arterio-venous malformations: preliminary results","volume":"15","author":"Bhatia K","year":"2023","unstructured":"Bhatia K, Lord D, McCowage G,  LB-002 Liquid biopsy identifies somatic KRAS mutations in paediatric cranio-spinal arterio-venous malformations: preliminary results. J Neurointerv Surg. 2023;15(Suppl 1):A243."},{"key":"b38","series-title":"Pediatr Stroke","first-page":"131","article-title":"Empiric treatment of metameric cerebrofacial arteriovenous malformation syndrome with trametinib-mediated MEK inhibition","volume":"9","author":"Eberle AT","year":"2024","unstructured":"Eberle AT, Winkler EA, Cooke DL,  Empiric treatment of metameric cerebrofacial arteriovenous malformation syndrome with trametinib-mediated MEK inhibition. Pediatr Stroke. 2024;9:131\u2013155."},{"issue":"3","key":"b1","series-title":"J Neurosurg","first-page":"352","article-title":"The natural-history of unruptured intracranial arteriovenous-malformations","volume":"68","author":"Brown RD","year":"1988","unstructured":"Brown RD, Wiebers DO, Forbes G,  The natural-history of unruptured intracranial arteriovenous-malformations. J Neurosurg. 1988;68(3):352\u2013357."},{"issue":"4","key":"b2","series-title":"J Neurosurg","first-page":"476","article-title":"A proposed grading system for arteriovenous malformations","volume":"65","author":"Spetzler RF","year":"1986","unstructured":"Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65(4):476\u2013483."},{"issue":"1","key":"b3","series-title":"J Neurosurg","first-page":"125","article-title":"Intermediate-grade brain arteriovenous malformations and the boundary of operability using the supplemented Spetzler-Martin grading system","volume":"136","author":"Catapano JS","year":"2022","unstructured":"Catapano JS, Frisoli FA, Nguyen CL,  Intermediate-grade brain arteriovenous malformations and the boundary of operability using the supplemented Spetzler-Martin grading system. J Neurosurg. 2022;136(1):125\u2013133."},{"issue":"6","key":"b4","series-title":"Neurosurgery","first-page":"1103","article-title":"Spetzler-Martin grade III arteriovenous malformations: a comparison of modified and supplemented Spetzler-Martin grading systems","volume":"88","author":"Frisoli FA","year":"2021","unstructured":"Frisoli FA, Catapano JS, Farhadi DS,  Spetzler-Martin grade III arteriovenous malformations: a comparison of modified and supplemented Spetzler-Martin grading systems. Neurosurgery. 2021;88(6):1103\u20131110."},{"issue":"2","key":"b5","series-title":"Oper Neurosurg (Hagerstown)","first-page":"136","article-title":"More II it than meets the eye: outcomes after single-fraction stereotactic radiosurgery in a case series of low-grade arteriovenous malformations","volume":"18","author":"Graffeo CS","year":"2020","unstructured":"Graffeo CS, Link MJ, Stafford SL, Garces YI, Foote RL, Pollock BE. More II it than meets the eye: outcomes after single-fraction stereotactic radiosurgery in a case series of low-grade arteriovenous malformations. Oper Neurosurg (Hagerstown). 2020;18(2):136\u2013144."},{"issue":"3","key":"b6","series-title":"J Neurosurg","first-page":"804","article-title":"Stereotactic radiosurgery for intermediate- and high-grade arteriovenous malformations: outcomes stratified by the supplemented Spetzler-Martin grading system","volume":"138","author":"Naylor RM","year":"2023","unstructured":"Naylor RM, Graffeo CS, Nesvick CL,  Stereotactic radiosurgery for intermediate- and high-grade arteriovenous malformations: outcomes stratified by the supplemented Spetzler-Martin grading system. J Neurosurg. 2023;138(3):804\u2013809."},{"issue":"3","key":"b7","series-title":"J Neurosurg","first-page":"859","article-title":"Stereotactic radiosurgery for Spetzler-Martin Grade III arteriovenous malformations: an international multicenter study","volume":"126","author":"Ding D","year":"2017","unstructured":"Ding D, Starke RM, Kano H,  Stereotactic radiosurgery for Spetzler-Martin Grade III arteriovenous malformations: an international multicenter study. J Neurosurg. 2017;126(3):859\u2013871."},{"issue":"2","key":"b8","series-title":"J Neurosurg","first-page":"498","article-title":"Stereotactic radiosurgery for Spetzler-Martin Grade IV and V arteriovenous malformations: an international multicenter study","volume":"129","author":"Patibandla MR","year":"2018","unstructured":"Patibandla MR, Ding D, Kano H,  Stereotactic radiosurgery for Spetzler-Martin Grade IV and V arteriovenous malformations: an international multicenter study. J Neurosurg. 2018;129(2):498\u2013507."},{"issue":"1","key":"b9","series-title":"Brain","first-page":"23","article-title":"High prevalence of KRAS\/BRAF somatic mutations in brain and spinal cord arteriovenous malformations","volume":"142","author":"Hong T","year":"2019","unstructured":"Hong T, Yan Y, Li J,  High prevalence of KRAS\/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. Brain. 2019;142(1):23\u201334."},{"issue":"3","key":"b10","series-title":"N Engl J Med","first-page":"250","article-title":"Somatic activating KRAS mutations in arteriovenous malformations of the brain","volume":"378","author":"Nikolaev SI","year":"2018","unstructured":"Nikolaev SI, Vetiska S, Bonilla X,  Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med. 2018;378(3):250\u2013261."},{"issue":"4","key":"b11","series-title":"N Engl J Med","first-page":"334","article-title":"Sotorasib for vascular malformations associated with KRAS G12C Mutation","volume":"391","author":"Fraissenon A","year":"2024","unstructured":"Fraissenon A, Bayard C, Morin G,  Sotorasib for vascular malformations associated with KRAS G12C Mutation. N Engl J Med. 2024;391(4):334\u2013342."},{"issue":"5","key":"b12","series-title":"Ann Neurol","first-page":"926","article-title":"Selective endothelial hyperactivation of oncogenic KRAS induces brain arteriovenous malformations in mice","volume":"89","author":"Park ES","year":"2021","unstructured":"Park ES, Kim S, Huang S,  Selective endothelial hyperactivation of oncogenic KRAS induces brain arteriovenous malformations in mice. Ann Neurol. 2021;89(5):926\u2013941."},{"issue":"6","key":"b13","series-title":"EMBO Mol Med","first-page":"609","article-title":"A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases","volume":"8","author":"K\u00f6rbelin J","year":"2016","unstructured":"K\u00f6rbelin J, Dogbevia G, Michelfelder S,  A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases. EMBO Mol Med. 2016;8(6):609\u2013625."},{"issue":"8013","key":"b14","series-title":"Nature","first-page":"927","article-title":"Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer","volume":"629","author":"Wasko UN","year":"2024","unstructured":"Wasko UN, Jiang J, Dalton TC,  Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Nature. 2024;629(8013):927\u2013936."},{"issue":"3","key":"b15","series-title":"Cancer Discov","first-page":"270","article-title":"Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors","volume":"2","author":"Sennino B","year":"2012","unstructured":"Sennino B, Ishiguro-Oonuma T, Wei Y,  Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Cancer Discov. 2012;2(3):270\u2013287."},{"key":"b16","series-title":"Front Immunol","first-page":"726421","article-title":"Microglia and perivascular macrophages act as antigen presenting cells to promote CD8 T cell infiltration of the brain","volume":"12","author":"Goddery EN","year":"2021","unstructured":"Goddery EN, Fain CE, Lipovsky CG,  Microglia and perivascular macrophages act as antigen presenting cells to promote CD8 T cell infiltration of the brain. Front Immunol. 2021;12:726421."},{"issue":"1","key":"b17","series-title":"Neuroradiology","first-page":"65","article-title":"Lack of aneurysm formation after carotid artery ligation in rabbits: a polymer MICROFIL\u00ae study","volume":"55","author":"Dai D","year":"2013","unstructured":"Dai D, Ding YH, Kadirvel R, Rad AE, Lewis DA, Kallmes DF. Lack of aneurysm formation after carotid artery ligation in rabbits: a polymer MICROFIL\u00ae study. Neuroradiology. 2013;55(1):65\u201370."},{"issue":"6","key":"b18","series-title":"Nat Cell Biol","first-page":"538","article-title":"Cyclin B2 and p53 control proper timing of centrosome separation","volume":"16","author":"Nam HJ","year":"2014","unstructured":"Nam HJ, van Deursen JM. Cyclin B2 and p53 control proper timing of centrosome separation. Nat Cell Biol. 2014;16(6):538\u2013549."},{"issue":"1","key":"b19","series-title":"Cardiovasc Diabetol","first-page":"388","article-title":"Dapagliflozin mitigates cellular stress and inflammation through PI3K\/AKT pathway modulation in cardiomyocytes, aortic endothelial cells, and stem cell-derived \u03b2 cells","volume":"23","author":"Alsereidi FR","year":"2024","unstructured":"Alsereidi FR, Khashim Z, Marzook H,  Dapagliflozin mitigates cellular stress and inflammation through PI3K\/AKT pathway modulation in cardiomyocytes, aortic endothelial cells, and stem cell-derived \u03b2 cells. Cardiovasc Diabetol. 2024;23(1):388."},{"issue":"7","key":"b20","series-title":"Nat Methods","first-page":"676","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin J","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E,  Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u2013682."},{"issue":"7","key":"b21","series-title":"Stroke","first-page":"1925","article-title":"Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain","volume":"43","author":"Walker EJ","year":"2012","unstructured":"Walker EJ, Su H, Shen F,  Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain. Stroke. 2012;43(7):1925\u20131930."},{"issue":"5","key":"b22","series-title":"J Neurosurg","first-page":"1566","article-title":"Effect of elevation of vascular endothelial growth factor level on exacerbation of hemorrhage in mouse brain arteriovenous malformation","volume":"132","author":"Cheng P","year":"2020","unstructured":"Cheng P, Ma L, Shaligram S,  Effect of elevation of vascular endothelial growth factor level on exacerbation of hemorrhage in mouse brain arteriovenous malformation. J Neurosurg. 2020;132(5):1566\u20131573."},{"issue":"3","key":"b23","series-title":"JAMA Netw Open","first-page":"e231070","article-title":"Development and validation of a scoring system for hemorrhage risk in brain arteriovenous malformations","volume":"6","author":"Chen Y","year":"2023","unstructured":"Chen Y, Han H, Meng X,  Development and validation of a scoring system for hemorrhage risk in brain arteriovenous malformations. JAMA Netw Open. 2023;6(3):e231070."},{"key":"b24","series-title":"JVS Vasc Sci","first-page":"176","article-title":"Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation","volume":"1","author":"Palmieri M","year":"2020","unstructured":"Palmieri M, Curr\u00f2 A, Tommasi A,  Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation. JVS Vasc Sci. 2020;1:176\u2013180."},{"issue":"16","key":"b25","series-title":"Neurology","first-page":"e1637","article-title":"Endoluminal biopsy for molecular profiling of human brain vascular malformations","volume":"98","author":"Winkler E","year":"2022","unstructured":"Winkler E, Wu D, Gil E,  Endoluminal biopsy for molecular profiling of human brain vascular malformations. Neurology. 2022;98(16):e1637\u2013e1647."},{"issue":"4","key":"b26","series-title":"Cancer Cell","first-page":"299","article-title":"Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors","volume":"8","author":"Casanovas O","year":"2005","unstructured":"Casanovas O, Hicklin DJ, Bergers G, Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell. 2005;8(4):299\u2013309."},{"issue":"52","key":"b27","series-title":"J Biol Chem","first-page":"49289","article-title":"Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation","volume":"276","author":"Meadows KN","year":"2001","unstructured":"Meadows KN, Bryant P, Pumiglia K. Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J Biol Chem. 2001;276(52):49289\u201349298."},{"issue":"6","key":"b28","series-title":"Biomedicines","first-page":"1289","article-title":"Defining the role of oral pathway inhibitors as targeted therapeutics in arteriovenous malformation care","volume":"12","author":"Mansur A","year":"2024","unstructured":"Mansur A, Radovanovic I. Defining the role of oral pathway inhibitors as targeted therapeutics in arteriovenous malformation care. Biomedicines. 2024;12(6):1289."},{"issue":"2","key":"b29","series-title":"Ther Adv Drug Saf","first-page":"59","article-title":"Risks and benefits with bevacizumab: evidence and clinical implications","volume":"3","author":"Kurkjian C","year":"2012","unstructured":"Kurkjian C, Kim ES. Risks and benefits with bevacizumab: evidence and clinical implications. Ther Adv Drug Saf. 2012;3(2):59\u201369."},{"issue":"2","key":"b30","series-title":"J Thorac Oncol","first-page":"268","article-title":"Rupture of a cerebral arteriovenous malformation in a patient treated with bevacizumab","volume":"4","author":"Tanvetyanon T","year":"2009","unstructured":"Tanvetyanon T, Murtagh R, Bepler G. Rupture of a cerebral arteriovenous malformation in a patient treated with bevacizumab. J Thorac Oncol. 2009;4(2):268\u2013269."},{"issue":"1","key":"b31","series-title":"BMJ Neurol Open","first-page":"e000114","article-title":"Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation","volume":"3","author":"Muster R","year":"2021","unstructured":"Muster R, Ko N, Smith W,  Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation. BMJ Neurol Open. 2021;3(1):e000114."},{"issue":"3","key":"b32","series-title":"Pediatrics","first-page":"e20193206","article-title":"Monitoring arteriovenous malformation response to genotype-targeted therapy","volume":"146","author":"Edwards EA","year":"2020","unstructured":"Edwards EA, Phelps AS, Cooke D,  Monitoring arteriovenous malformation response to genotype-targeted therapy. Pediatrics. 2020;146(3):e20193206."},{"issue":"2","key":"b33","series-title":"JAMA Dermatol","first-page":"256","article-title":"Genotype-guided medical treatment of an arteriovenous malformation in a child","volume":"155","author":"Lekwuttikarn R","year":"2019","unstructured":"Lekwuttikarn R, Lim YH, Admani S, Choate KA, Teng JMC. Genotype-guided medical treatment of an arteriovenous malformation in a child. JAMA Dermatol. 2019;155(2):256\u2013257."},{"issue":"2","key":"b34","series-title":"Pediatr Dermatol","first-page":"316","article-title":"Successful management of an arteriovenous malformation with trametinib in a patient with capillary-malformation arteriovenous malformation syndrome and cardiac compromise","volume":"39","author":"Nicholson CL","year":"2022","unstructured":"Nicholson CL, Flanagan S, Murati M,  Successful management of an arteriovenous malformation with trametinib in a patient with capillary-malformation arteriovenous malformation syndrome and cardiac compromise. Pediatr Dermatol. 2022;39(2):316\u2013319."},{"issue":"Suppl 1","key":"b35","series-title":"Blood","first-page":"5418","article-title":"Response to dabrafenib and tramatenib in an extra-cranial AVM with BRAF V600E Mutation","volume":"142","author":"Fraustro M","year":"2023","unstructured":"Fraustro M, Olsen B, Khatib Z. Response to dabrafenib and tramatenib in an extra-cranial AVM with BRAF V600E Mutation. Blood. 2023;142(Suppl 1):5418."},{"issue":"3","key":"b36","series-title":"J Vasc Anom (Phila)","first-page":"e018","article-title":"Angiographic evidence of response to trametinib therapy for a spinal cord arteriovenous malformation","volume":"2","author":"Cooke DL","year":"2021","unstructured":"Cooke DL, Frieden IJ, Shimano KA. Angiographic evidence of response to trametinib therapy for a spinal cord arteriovenous malformation. J Vasc Anom (Phila). 2021;2(3):e018."},{"issue":"Suppl 1","key":"b37","series-title":"J Neurointerv Surg","first-page":"A243","article-title":"LB-002 Liquid biopsy identifies somatic KRAS mutations in paediatric cranio-spinal arterio-venous malformations: preliminary results","volume":"15","author":"Bhatia K","year":"2023","unstructured":"Bhatia K, Lord D, McCowage G,  LB-002 Liquid biopsy identifies somatic KRAS mutations in paediatric cranio-spinal arterio-venous malformations: preliminary results. J Neurointerv Surg. 2023;15(Suppl 1):A243."},{"key":"b38","series-title":"Pediatr Stroke","first-page":"131","article-title":"Empiric treatment of metameric cerebrofacial arteriovenous malformation syndrome with trametinib-mediated MEK inhibition","volume":"9","author":"Eberle AT","year":"2024","unstructured":"Eberle AT, Winkler EA, Cooke DL,  Empiric treatment of metameric cerebrofacial arteriovenous malformation syndrome with trametinib-mediated MEK inhibition. Pediatr Stroke. 2024;9:131\u2013155."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/144\/2\/article-p452.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/144\/2\/article-p452.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/144\/2\/article-p452.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:30:55Z","timestamp":1772721055000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/144\/2\/article-p452.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":76,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2025.7.jns25708","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]}}}